A randomized controlled trial of cognitive-behavior therapy for persistent symptoms in schizophrenia: a five-year follow-up.

Abstract:

:Meta-analyses of randomized controlled trials support the efficacy of cognitive behavioral therapy (CBT) in the treatment of symptoms of schizophrenia refractory to antipsychotic medication. This article addresses the issue of medium term durability. A five-year follow-up was undertaken of a sample of 90 subjects who participated in a randomized controlled trial of CBT and befriending (BF). Patients received routine care throughout the trial and the follow-up period. Intention to treat multivariate analysis was performed by an independent statistician following multiple imputation of missing data. Fifty-nine out of ninety patients were followed up at 5 years (CBT=31, BF=28). In comparison to BF and usual treatment, CBT showed evidence of a significantly greater and more durable effect on overall symptom severity (NNT=10.36, CI -10.21, 10.51) and level of negative symptoms (NNT=5.22, CI -5.06 -5.37). No difference was found between CBT and BF on either overall symptoms of schizophrenia or depression. The initial cost of an adjunctive course of CBT for individuals with medication refractory schizophrenia may be justified in light of symptomatic benefits that persist over the medium term.

journal_name

Schizophr Res

journal_title

Schizophrenia research

authors

Turkington D,Sensky T,Scott J,Barnes TR,Nur U,Siddle R,Hammond K,Samarasekara N,Kingdon D

doi

10.1016/j.schres.2007.09.026

subject

Has Abstract

pub_date

2008-01-01 00:00:00

pages

1-7

issue

1-3

eissn

0920-9964

issn

1573-2509

pii

S0920-9964(07)00431-8

journal_volume

98

pub_type

杂志文章,随机对照试验
  • Comparing the prodrome of schizophrenia-spectrum psychoses and affective disorders with and without psychotic features.

    abstract:OBJECTIVE:Following encouraging results in the early detection of psychotic disorders, interest in the early detection of affective, especially bipolar disorders, has recently been renewed. However, the differentiation between affective disorders with and without psychotic features is often missing, although it has bee...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2012.04.001

    authors: Schultze-Lutter F,Schimmelmann BG,Klosterkötter J,Ruhrmann S

    更新日期:2012-07-01 00:00:00

  • Automatic affective processing impairments in patients with deficit syndrome schizophrenia.

    abstract::Affective impairments were examined in patients with and without deficit syndrome schizophrenia. Two Emotional Stroop tasks designed to measure automatic processing of emotional information were administered to deficit (n=15) and non-deficit syndrome (n=26) schizophrenia patients classified according to the Schedule f...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2008.01.014

    authors: Strauss GP,Allen DN,Duke LA,Ross SA,Schwartz J

    更新日期:2008-07-01 00:00:00

  • Seasonal influences on admissions in schizophrenia and affective disorder in Ireland.

    abstract::Although the seasonal patterns of admissions of affective disorder have been extensively studied, less attention has been given to the seasonal admission patterns of schizophrenia. The traditional method of aggregating the data over a study period, rather than analysing by year of admission may obscure potentially rel...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(98)00106-6

    authors: Clarke M,Moran P,Keogh F,Morris M,Kinsella A,Walsh D,Larkin C,O'Callaghan E

    更新日期:1998-11-30 00:00:00

  • Why you can't be in sync with schizophrenia patients.

    abstract::Most individuals with schizophrenia will be confronted with some form of stigma. In recent years, clinicians and family members have increasingly contested the term "schizophrenia". Many of them discuss changing this name, as a means to fight stigma. Up until now, surprisingly, most research has been conducted using s...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2019.11.054

    authors: Rainteau N,Salesse RN,Macgregor A,Macioce V,Raffard S,Capdevielle D

    更新日期:2020-02-01 00:00:00

  • Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia.

    abstract::Glutamate transporters facilitate the buffering, clearance and cycling of glutamate and play an important role in maintaining synaptic and extrasynaptic glutamate levels. Alterations in glutamate transporter expression may lead to abnormal glutamate neurotransmission contributing to the pathophysiology of schizophreni...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2012.12.019

    authors: Shan D,Lucas EK,Drummond JB,Haroutunian V,Meador-Woodruff JH,McCullumsmith RE

    更新日期:2013-03-01 00:00:00

  • A two-method meta-analysis of Neuregulin 1(NRG1) association and heterogeneity in schizophrenia.

    abstract::NRG1 is one of the most researched genes associated with schizophrenia. Although three meta-analyses in this area have been published, the results have been inconclusive and even conflicting. Family based studies can be problematical due to the difficulty of synthesizing them with case-control studies. Heterogeneity i...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2009.03.017

    authors: Gong YG,Wu CN,Xing QH,Zhao XZ,Zhu J,He L

    更新日期:2009-06-01 00:00:00

  • A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia.

    abstract::Schizophrenia is associated with significant impairments in both higher and lower order social cognitive performance and these impairments contribute to poor social functioning. People with schizophrenia report poor social functioning to be one of their greatest unmet treatment needs. Recent studies have suggested the...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2015.06.005

    authors: Guastella AJ,Ward PB,Hickie IB,Shahrestani S,Hodge MA,Scott EM,Langdon R

    更新日期:2015-11-01 00:00:00

  • Structural and functional reorganization of working memory system during the first decade in schizophrenia. A cross-sectional study.

    abstract:INTRODUCTION:Progressive atrophy occurs in brain regions involved in the working memory network along the schizophrenia's course, but without parallel evolution of working memory impairment. We investigated the functional organization inside this network at different stages of the disease. METHODS:Twenty-eight patient...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2013.10.023

    authors: Faget-Agius C,Boyer L,Lançon C,Richieri R,Fassio E,Soulier E,Chanoine V,Auquier P,Ranjeva JP,Guye M

    更新日期:2013-12-01 00:00:00

  • The influence of adjunctive treatment and metacognitive deficits in schizophrenia on the experience of work.

    abstract::Enhancing work function is now widely considered a core element of comprehensive schizophrenia treatment. While research efforts have illuminated factors that influence how well patients perform at work, less is known about the factors influencing the subjective experience of work. It is not known how, and to what ext...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2014.04.017

    authors: de Jong S,Renard SB,van Donkersgoed RJ,van der Gaag M,Wunderink L,Pijnenborg GH,Lysaker PH

    更新日期:2014-08-01 00:00:00

  • Cytochrome P450 genotypes are not associated with refractoriness to antipsychotic treatment.

    abstract::Evidence validating the influence of the cytochrome P450 (CYP) 2D6 and 2C19 enzymes genetic polymorphisms in the response to antipsychotics is scarce. We examined the hypothesis that a higher prevalence of CYP2D6 and/or CYP2C19 ultra rapid metabolizers might be found among refractory schizophrenia patients. Three grou...

    journal_title:Schizophrenia research

    pub_type: 信件

    doi:10.1016/j.schres.2015.08.002

    authors: van de Bilt MT,Prado CM,Ojopi EP,Sousa RT,Loch AA,Zanetti MV,Talib LL,Gattaz WF

    更新日期:2015-10-01 00:00:00

  • Olfactory identification deficit in relation to schizotypy.

    abstract::Past studies have shown that schizophrenic men tend to be impaired on the olfactory identification task. We examined individual differences in the olfactory function in relation to schizotypy. Healthy individuals who might carry latent liability for schizophrenia participated in olfactory identification and acuity tas...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(97)00045-5

    authors: Park S,Schoppe S

    更新日期:1997-08-29 00:00:00

  • Elevated GRIA1 mRNA expression in Layer II/III and V pyramidal cells of the DLPFC in schizophrenia.

    abstract::The functional integrity of the dorsolateral prefrontal cortex (DLPFC) is altered in schizophrenia leading to profound deficits in working memory and cognition. Growing evidence indicates that dysregulation of glutamate signaling may be a significant contributor to the pathophysiology mediating these effects; however,...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2007.09.022

    authors: O'Connor JA,Hemby SE

    更新日期:2007-12-01 00:00:00

  • Increased platelet phospholipase A2 activity in schizophrenia.

    abstract::The intracellular enzyme phospholipase A2 (PLA2) plays an essential role in the breakdown of membrane phospholipids, which regulate the physicochemical properties of the cell membrane. In the brain PLA2 has been reported to influence receptor function and signal transduction. Regarding dopaminergic neurons, data from ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(94)00060-l

    authors: Gattaz WF,Schmitt A,Maras A

    更新日期:1995-07-01 00:00:00

  • Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study.

    abstract:OBJECTIVE:Research participants must have adequate consent-related abilities to provide informed consent at the time of study enrollment. We sought to determine if research participants with schizophrenia maintain adequate consent-related abilities during a longitudinal study. If participants lose abilities during a tr...

    journal_title:Schizophrenia research

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/j.schres.2011.04.012

    authors: Stroup TS,Appelbaum PS,Gu H,Hays S,Swartz MS,Keefe RS,Kim SY,Manschreck TC,Boshes RA,McEvoy JP,Lieberman JA

    更新日期:2011-08-01 00:00:00

  • Empathy, schizophrenia and violence: a systematic review.

    abstract:BACKGROUND:A small but significant association between schizophrenia and violence is open to a number of explanations. Impaired empathy has been associated with schizophrenia, and with violence in the general population. Our aim was to conduct a systematic review of any research into relationships between schizophrenia...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2012.07.019

    authors: Bragado-Jimenez MD,Taylor PJ

    更新日期:2012-10-01 00:00:00

  • The relationship between suicide and violence in schizophrenia: analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) dataset.

    abstract:BACKGROUND:Suicide and violence often co-occur in the general population as well as in mentally ill individuals. Few studies, however, have assessed whether these suicidal behaviors are predictive of violence risk in mental illness. AIMS:The aim of this study is to investigate whether suicidal behaviors, including sui...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2014.02.001

    authors: Witt K,Hawton K,Fazel S

    更新日期:2014-04-01 00:00:00

  • Corpus callosum and P300 in schizophrenia.

    abstract::Functional abnormalities in the interhemispheric transfer via the corpus callosum in schizophrenia may result in filtering problems and information processing problems, which may in turn be related to the synchronization of cortical event-related activity. To explore whether a relationship exists between corpus callos...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(00)00123-7

    authors: Frodl T,Meisenzahl EM,Müller D,Greiner J,Juckel G,Leinsinger G,Hahn H,Möller HJ,Hegerl U

    更新日期:2001-04-15 00:00:00

  • Schizophrenic births and viral diseases in two states.

    abstract::In order to investigate a possible relationship between schizophrenic births and viral diseases, the birth month and year of all state hospital admissions for schizophrenia in Connecticut and Massachusetts from 1973-1974 were compared with the occurrence of reportable viral diseases for 1920-1955. Data was statistical...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(88)90043-6

    authors: Torrey EF,Rawlings R,Waldman IN

    更新日期:1988-01-01 00:00:00

  • Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy.

    abstract:BACKGROUND:In recent years, schizophrenia has increasingly been recognized as a neurocognitive disorder, which has led to a growing literature on cognitive rehabilitation, and suggested several potential enhancements to cognitive function. For instance, it has been shown that executive functioning deficits as measured ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2008.08.005

    authors: Ohrmann P,Kugel H,Bauer J,Siegmund A,Kölkebeck K,Suslow T,Wiedl KH,Rothermundt M,Arolt V,Pedersen A

    更新日期:2008-12-01 00:00:00

  • The relationship between clinical and biochemical changes following neuroleptic treatment in schizophrenia.

    abstract::Clinical improvement in psychotic symptoms is not immediate when neuroleptic treatment is commenced. Previous studies have demonstrated the development of biochemical tolerance to the effects of neuroleptics on the dopamine system. This study demonstrates a relationship between this biochemical change and the clinical...

    journal_title:Schizophrenia research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0920-9964(90)90007-t

    authors: Cooper SJ,Leahey W,Liddle J,King DJ

    更新日期:1990-07-01 00:00:00

  • Psychosis risk screening with the Prodromal Questionnaire--brief version (PQ-B).

    abstract::In this study, we examined the preliminary concurrent validity of a brief version of the Prodromal Questionnaire (PQ-B), a self-report screening measure for psychosis risk syndromes. Adolescents and young adults (N=141) who presented consecutively for clinical assessment to one of two early psychosis research clinics ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.schres.2011.03.029

    authors: Loewy RL,Pearson R,Vinogradov S,Bearden CE,Cannon TD

    更新日期:2011-06-01 00:00:00

  • The association of neurocognitive impairment with diminished expression and apathy in schizophrenia.

    abstract::Negative symptoms can be grouped into the two dimensions of diminished expression and apathy, which have been shown to be dissociable regarding external validators, such as functional outcome. Here, we investigated whether these two dimensions differentially relate to neurocognitive impairment in schizophrenia. 47 pat...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2015.10.032

    authors: Hartmann-Riemer MN,Hager OM,Kirschner M,Bischof M,Kluge A,Seifritz E,Kaiser S

    更新日期:2015-12-01 00:00:00

  • International clinical trials with applicability to mentally impaired individuals: the conundrum of third world sites.

    abstract::Research on the effectiveness of treatment programs in early stages of severe mental illness raise significant ethical questions when conducted in industrialized countries that have adequate protections for the human subjects of biomedical and behavioral research. Before embarking on similar trials in developing count...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(01)00244-4

    authors: Macklin R

    更新日期:2001-08-01 00:00:00

  • Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment.

    abstract:PURPOSE:The excitatory neurotransmitter glutamate has become an important area of focus for schizophrenia researchers. Polymorphisms in the type-three metabotropic glutamate receptor gene (GRM3) have been associated with the pathogenesis of schizophrenia. The purpose of this study was to determine whether a pharmacogen...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2005.04.001

    authors: Bishop JR,Ellingrod VL,Moline J,Miller D

    更新日期:2005-09-15 00:00:00

  • Speech illusions and working memory performance in non-clinical psychosis.

    abstract::Psychotic disorders are characterized by auditory verbal hallucinations (AVHs), and research has shown that AVHs are linked to deficits in working memory. Our understanding of AVHs across the psychosis continuum is limited. To date, little research has tested whether hallucination proneness (HP) is linked with abnorma...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2017.10.031

    authors: Gupta T,DeVylder JE,Auerbach RP,Schiffman J,Mittal VA

    更新日期:2018-05-01 00:00:00

  • Dedifferentiation and substitute strategy: deconstructing the processing-speed impairment in schizophrenia.

    abstract:BACKGROUND:Recent research has identified impairment in processing speed, measured by the digit-symbol substitution task, as central to the cognitive deficit in schizophrenia. However, the underlying cognitive correlates of this impairment remain unknown. METHODS:A sample of cases (N=125) meeting DSM-IV criteria for s...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2012.08.020

    authors: Knowles EE,Weiser M,David AS,Dickinson D,Glahn D,Gold J,Davidson M,Reichenberg A

    更新日期:2012-12-01 00:00:00

  • On the boundaries of blunt affect/alogia across severe mental illness: implications for Research Domain Criteria.

    abstract::There is growing awareness that reduced expressive behaviors (e.g., blunt affect, alogia, psychomotor retardation) are characteristic of a range of psychiatric conditions, including mood and schizophrenia-spectrum disorders. From a Research Domain Criteria (RDoC) perspective, it would be critical to determine whether ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2012.07.001

    authors: Cohen AS,Najolia GM,Kim Y,Dinzeo TJ

    更新日期:2012-09-01 00:00:00

  • Dose equivalents for second generation long-acting injectable antipsychotics: The minimum effective dose method.

    abstract:BACKGROUND:The concept of dose equivalence of depot medication is important for many scientific and clinical purposes. METHODS:A systematic literature search on four second-generation antipsychotics available as long-acting injectable drugs and haloperidol was conducted. We used the minimum effective dose method which...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2017.07.033

    authors: Rothe PH,Heres S,Leucht S

    更新日期:2018-03-01 00:00:00

  • Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development.

    abstract::Research into the neurobiological processes that may lead to the onset of schizophrenia places growing emphasis on the glutamatergic system and brain development. Preclinical studies have shown that neurodevelopmental, genetic, and environmental factors contribute to glutamatergic dysfunction and schizophrenia-related...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2020.09.013

    authors: Egerton A,Grace AA,Stone J,Bossong MG,Sand M,McGuire P

    更新日期:2020-09-01 00:00:00

  • Abnormal GABAergic function and face processing in schizophrenia: A pharmacologic-fMRI study.

    abstract::The involvement of the gamma-aminobutyric acid (GABA) system in schizophrenia is suggested by postmortem studies and the common use of GABA receptor-potentiating agents in treatment. In a recent study, we used a benzodiazepine challenge to demonstrate abnormal GABAergic function during processing of negative visual st...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2015.08.022

    authors: Tso IF,Fang Y,Phan KL,Welsh RC,Taylor SF

    更新日期:2015-10-01 00:00:00